Search results
1 day ago · Martine Rothblatt, the Chairperson and CEO of United Therapeutics (NASDAQ: UTHR) Corporation ( NASDAQ :UTHR), recently sold a substantial amount of company stock, according to the latest SEC filings. The transactions, which occurred on July 23 and 24, involved the sale of United Therapeutics shares at prices ranging from $331.7005 to $337.33 ...
1 day ago · Martine Rothblatt, présidente-directrice générale de United Therapeutics Corporation (NASDAQ:UTHR), a récemment vendu une quantité importante d'actions de la société, selon les derniers documents déposés auprès de la SEC. Les transactions, qui ont eu lieu les 23 et 24 juillet, ont ...
7 hours ago · Also, CEO Martine A. Rothblatt sold 3,600 shares of the company’s stock in a transaction on Wednesday, July 24th. The shares were sold at an average price of $334.00, for a total value of ...
7 hours ago · Paradigm-shifting consequences. Importantly, Campbell’s version of the simulation hypothesis differs from the ‘ancestor simulation’ thought experiment popularized by philosopher Dr. Nick Bostrom. “Contrary to what Bostrom postulates, the idea here is that consciousness is not a product of the simulation — it is fundamental to reality ...
7 hours ago · A loss of controlled inhibition of overly excited brain cells might explain how a common knock-out anesthesia drug works. A new animal study led by researchers from the Massachusetts Institute of Technology (MIT) has found that propofol, a sedative used to safely lull people into unconsciousness for medical procedures, disrupts the brain’s normal ability to regain control of highly excitable ...
